학술논문
Efficacy and Safety of Caspofungin Treatment in Febrile Neutropenic Patients with Hematological Disorders: A Multicenter Consecutive Case Series
Document Type
Journal Article
Author
Source
Internal Medicine. 2022, 61(20):3037
Subject
Language
English
ISSN
0918-2918
1349-7235
1349-7235
Abstract
Results The efficacy rate was 53.8% (28/52), which is close to the average reported efficacy rate. Adverse events included liver dysfunction and electrolyte abnormalities, but no renal dysfunction or serious events were seen.